Phio Pharmaceuticals (PHIO) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free PHIO Stock Alerts $0.80 -0.04 (-4.78%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePhio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)globenewswire.com - April 30 at 7:30 AMPhio Pharmaceuticals reports progress on cancer therapy PH-762investing.com - April 24 at 11:06 AMWhy Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?benzinga.com - April 22 at 3:21 PMIntratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cellsfinance.yahoo.com - April 22 at 3:21 PMIntratumoral Injection of Phio's PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cellsglobenewswire.com - April 22 at 1:10 PMPhio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)globenewswire.com - April 16 at 7:30 AMPhio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)globenewswire.com - April 11 at 7:30 AMNational Spotlight Features Phio’s Innovative RNAi Technology Platformfinance.yahoo.com - April 3 at 10:33 AMNational Spotlight Features Phio's Innovative RNAi Technology Platformglobenewswire.com - April 3 at 7:30 AMPhio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Updateglobenewswire.com - April 2 at 7:30 AMPhio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignanciesfinance.yahoo.com - March 21 at 7:52 AMPhio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Researchglobenewswire.com - March 13 at 2:00 PMPhio Pharmaceuticals Corp PHIOmorningstar.com - March 10 at 7:10 AMAnalysts Are Bullish on These Healthcare Stocks: Neurogene (NGNE), Akero Therapeutics (AKRO)markets.businessinsider.com - March 6 at 6:26 PMPhio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disordersfinance.yahoo.com - March 6 at 6:26 PMPhio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company's Intellectual Property Position in Treating Aging Skin and Skin Disordersglobenewswire.com - March 6 at 10:30 AMDry Age Related Macular Degeneration Market Report 2024: Global Trends, Forecasts and Competitive Analysis 2018-2023 and 2024-2030uk.finance.yahoo.com - February 14 at 10:33 AMAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Phio Pharmaceuticals (PHIO)markets.businessinsider.com - February 6 at 1:30 PMPhio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignanciesfinance.yahoo.com - January 31 at 8:14 AMPhio Pharmaceuticals files to sell 4.42M shares of common stock for holdersmsn.com - December 19 at 9:00 PMWhy Phio Pharmaceuticals Stock Is Nosedivingmsn.com - December 7 at 5:55 PMPhio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceedsfinance.yahoo.com - December 7 at 12:54 PMPhio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - November 10 at 1:31 PMPhio Pharmaceuticals GAAP EPS of -$1.14 beats by $0.29msn.com - November 10 at 1:31 PMPhio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 9 at 8:25 PMPhio Pharmaceuticals Announces First US Patient Enrolled in Phase 1B Clinical Trial with Intratumoral PH-762 anti-PD-1 Therapy for Treatment of Skin Carcinomasfinance.yahoo.com - November 9 at 10:25 AMPhio Pharmaceuticals Corp.: Phio Pharmaceuticals Presents New Data Showing INTASYL Compound targeting CTLA-4 Enhances Tumor Controlfinanznachrichten.de - November 3 at 3:18 PMPhio Pharmaceuticals Presents New Data Showing INTASYL Compound targeting CTLA-4 Enhances Tumor Controlfinance.yahoo.com - November 3 at 3:18 PMPhio Pharmaceuticals Announces Upcoming Presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)finance.yahoo.com - October 12 at 1:07 PMPHIO Jumps 91% on Encouraging Preclinical Cancer Drug Datafinance.yahoo.com - October 12 at 1:07 PMPhio Pharmaceuticals Shares Up 60% on Favorable PH-894 Preclinical Datamarketwatch.com - October 11 at 8:21 PMCrude Oil Down 2.5%; Silk Road Medical Shares Plummetmarkets.businessinsider.com - October 11 at 3:16 PMPhio Pharmaceuticals, Exscientia among healthcare moversmsn.com - October 11 at 3:16 PMWhy Is Immuno-Oncology Focused Phio Pharmaceuticals Stock Trading Higher Today?benzinga.com - October 11 at 3:16 PMPhio Pharmaceuticals Presents New Data for Targeting of BRD4 with its INTASYL™ Compound PH-894finance.yahoo.com - October 11 at 10:16 AMPhio CEO to Speak at Wainwright Conference in New York in Septemberfinance.yahoo.com - September 6 at 12:01 PMPhio CEO to Speak at Wainwright Conference in New York in Septemberfinance.yahoo.com - September 6 at 12:01 PMPhio’s partners dose first patient in cancer combo therapy trialmsn.com - August 22 at 8:35 AMPhio Pharmaceuticals Announces Dosing of First Patient in Collaborative Clinical Trial with AgonOx, Inc. and Providence Cancer Institutefinance.yahoo.com - August 21 at 5:31 PMH.C. Wainwright Sticks to Its Buy Rating for Phio Pharmaceuticals (PHIO)markets.businessinsider.com - August 16 at 7:42 AMPhio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - August 11 at 4:45 AMPhio Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - August 10 at 5:42 PMRNAi Drug Delivery Market worth $109.73 billion between 2022-2027- Exclusive report by Technaviouk.finance.yahoo.com - July 27 at 5:30 AMPHIO - Phio Pharmaceuticals Corp.finance.yahoo.com - July 19 at 10:30 AMPhio Pharmaceuticals Announces Closing of $4 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - June 2 at 6:07 PMPhio Pharmaceuticals Shares Drop 16% After Stock Offerings Pricemarketwatch.com - May 31 at 1:06 PMPhio Pharmaceuticals Announces $4 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - May 31 at 8:05 AMPhio Pharmaceuticals Can Begin Trial for Cancer Treatment PH-762marketwatch.com - May 24 at 9:10 AMPhio Pharmaceuticals Announces Initiation of Collaborative Clinical Trial with PH-762, AgonOx's Tumor Infiltrating Lymphocyte Program (AGX148) and Providence Cancer Institutefinance.yahoo.com - May 24 at 9:10 AMWhy DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarketmsn.com - May 19 at 1:05 PM Get Phio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PHIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. PHIO Media Mentions By Week PHIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHIO News Sentiment▼0.000.37▲Average Medical News Sentiment PHIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHIO Articles This Week▼01▲PHIO Articles Average Week Get Phio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PHIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALZN News Today REVB News Today GOVX News Today EVOK News Today BCEL News Today ARTL News Today CLVR News Today ENSC News Today LGVN News Today SNGX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHIO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phio Pharmaceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
